| 8201 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8202 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
64 |
| 8203 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
48 |
| 8204 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2015 |
Standard Therapy |
Germany |
49 |
| 8205 |
Apheresis |
Allogeneic |
Multiple Myeloma, Second Acute Myeloid Leukemia |
Hematology |
2015 |
Standard Therapy |
Germany |
64 |
| 8206 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
57 |
| 8207 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
60 |
| 8208 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
29 |
| 8209 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2015 |
Standard Therapy |
Germany |
73 |
| 8210 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
62 |
| 8211 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
22 |
| 8212 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8213 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2015 |
Standard Therapy |
Germany |
54 |
| 8214 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
61 |
| 8215 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
41 |
| 8216 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
70 |
| 8217 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2015 |
Standard Therapy |
Germany |
70 |
| 8218 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2015 |
Standard Therapy |
Germany |
44 |
| 8219 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2014 |
Experimental Therapy |
Poland |
6 |
| 8220 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2014 |
Experimental Therapy |
Poland |
60,1 |
| 8221 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2014 |
Experimental Therapy |
Poland |
24,1 |
| 8222 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2014 |
Experimental Therapy |
Poland |
12,6 |
| 8223 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2014 |
Experimental Therapy |
Poland |
8,3 |
| 8224 |
Cord Tissue |
Allogeneic – Unrelated |
Birth Asphyxia; Retinopathy |
Neurology |
2014 |
Experimental Therapy |
Poland |
11 months |
| 8225 |
Cord Tissue |
Allogeneic – Unrelated |
Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth |
Neurology |
2014 |
Experimental Therapy |
Poland |
2,1 |
| 8226 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Poland |
4,1 |
| 8227 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Poland |
15,1 |
| 8228 |
Cord Tissue |
Allogeneic – Unrelated |
Muscular Dystrophy |
Neurology |
2014 |
Experimental Therapy |
Poland |
6 |
| 8229 |
Cord Tissue |
Allogeneic – Unrelated |
Neuropathy |
Neurology |
2014 |
Experimental Therapy |
Poland |
23,6 |
| 8230 |
Cord Blood |
Allogeneic – Unrelated |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Spain |
15 |
| 8231 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Turkey |
8,8 |
| 8232 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
45 |
| 8233 |
Cord Blood |
Autologous |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Portugal |
6 |
| 8234 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2014 |
Standard Therapy |
Germany |
6 |
| 8235 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Portugal |
4 |
| 8236 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
UK |
1 |
| 8237 |
Cord Blood |
Autologous |
Hsv Encephalitis And Nmda Receptor Antibody Encephalitis |
Neurology |
2014 |
Experimental Therapy |
UK |
2 |
| 8238 |
Cord Blood |
Autologous |
Hypoxia-Ischemic Encephalopathy (Hie) |
Neurology |
2014 |
Experimental Therapy |
UK |
3 months |
| 8239 |
Cord Blood |
Allogeneic – Related |
Leukemia |
Hematology |
2014 |
Standard Therapy |
UK |
4 |
| 8240 |
Cord Blood |
Autologous |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
11 |
| 8241 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
35 |
| 8242 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
73 |
| 8243 |
Bone Marrow |
Allogeneic |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8244 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8245 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8246 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8247 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8248 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8249 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8250 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
29 |
| 8251 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
76 |
| 8252 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
48 |
| 8253 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8254 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
45 |
| 8255 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
27 |
| 8256 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8257 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
46 |
| 8258 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
67 |
| 8259 |
Apheresis |
Autologous |
Bing–Neel Syndrome; Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8260 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
42 |
| 8261 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
57 |
| 8262 |
Apheresis |
Allogeneic |
Composite Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8263 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8264 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
50 |
| 8265 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8266 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2014 |
Standard Therapy |
Germany |
24 |
| 8267 |
Apheresis |
Autologous |
Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8268 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8269 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8270 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
58 |
| 8271 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8272 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8273 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8274 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
68 |
| 8275 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8276 |
Apheresis |
Autologous |
Marginal Zone Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8277 |
Apheresis |
Allogeneic |
Morbus Hodgkin |
Hematology |
2014 |
Standard Therapy |
Germany |
31 |
| 8278 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8279 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
37 |
| 8280 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
19 |
| 8281 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
70 |
| 8282 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
71 |
| 8283 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8284 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
71 |
| 8285 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
66 |
| 8286 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8287 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8288 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8289 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8290 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
30 |
| 8291 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8292 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
70 |
| 8293 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
77 |
| 8294 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8295 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8296 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8297 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8298 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8299 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
68 |
| 8300 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
49 |